Showing results (11-20 of 4,868) with videos related to

Sort By:
Pageof 487
Urologic Oncology|November 8, 2015
Surgical considerations for patients with metastatic renal cell carcinomaMehrad Adibi, Arun Z Thomas, Leonardo D Borregales, et al.
Urologic Oncology|November 8, 2015
Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbiditiesScott M Haake, Samira A Brooks, Eric Welsh, et al.
Urologic Oncology|June 23, 2016
Enzalutamide inhibits androgen receptor-positive bladder cancer cell growthTakashi Kawahara, Hiroki Ide, Eiji Kashiwagi, et al.
Urologic Oncology|August 18, 2015
Underuse and underreporting of smoking cessation for smokers with a new urologic cancer diagnosisLiam C Macleod, Jessica C Dai, Sarah K Holt, et al.
Urologic Oncology|July 29, 2015
State of the art in germ cell tumor imagingMustafa Secil, Canan Altay, Isil Basara
Urologic Oncology|April 25, 2016
Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancerDerek R McHaffie, Tim J Kruser, Kris Gaston, et al.
Urologic Oncology|March 6, 2016
Quality of life in patients with cisplatin-resistant urothelial cancer: Typical ailments and effect of paclitaxel-based salvage therapyGuenter Niegisch, Margitta Retz, Roswitha Siener, et al.
Urologic Oncology|March 8, 2016
Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomyDaniel P Nguyen, Emily A Vertosick, Renato B Corradi, et al.
Urologic Oncology|March 13, 2016
Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomesWei Shen Tan, Ashwin Sridhar, Gidon Ellis, et al.
Urologic Oncology|March 15, 2016
Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomyHarun Fajkovic, Romain Mathieu, Ilaria Lucca, et al.
Pageof 487